Press Releases
 
Fragment-based Drug Discovery Market Will be Worth US$1.15 bn by 2023

, 19 April 2019 -- Fragment-based Drug Discovery Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Fragment-based Drug Discovery Market: Snapshot

The introduction of new techniques into the existing fragment-based drug discovery practices have created significant reductions in time and cost, driving the demand for such practices. Combinational chemistry and high-throughput screening are some of the more recently introduced practices that have helped make fragment-based drug discovery programs a lot faster and cheaper than before.

Additionally, as the usage of fragment-based drug discovery grows in the field of discovering weaker inhibitors, biophysical techniques become extremely useful. These techniques can be used to measure binding within fragment compounds that possess low affinity for binding.

Obtain Report Details @ https://www.transparencymarketresearch.com/fragment-based-drug-discovery-market.html

The demand for fragment-based drug discovery, however, is expected to be greatly hindered by the lowered potency of fragment screening, the most popular component, in certain compounds. The drugs generated have a lower than required potency, thus deterring several end users from approaching this technique.

The collective impact of all such drivers and restraints can be seen on the global fragment-based drug discovery market, which is expected to expand at a CAGR of 14.4% from 2015 to 2023 by revenue. By the end of 2016, this revenue is expected to reach US$435.6 mn and US$1.15 bn by the end of 2023.

Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4741

North America Expected to Continue Leading Demand for Fragment-based Drug Discovery Programs

By the end of 2023, the market value of fragment-based drug discovery techniques in North America is expected to be 45.4% of the global market. While this is a drop in market value from its 2014 statistic, North America will still enjoy being a leading geographical segment for advancements in fragment-based drug discovery techniques.

The key factors responsible for the leading role of North America in fragment-based drug discovery programs is the high rate of research and development efforts undertaken by prominent market players in the region. The U.S. and Canada are both countries with advanced healthcare systems and infrastructures, and are often the base of advanced technological implementations, making North America the hub for the latest developments in fragment-based drug discovery.

This region is also ramping up its speed in development of fragment-based drug discovery techniques by employing outsourcing facilities from Asia Pacific. The demand for fragment-based drug discovery in Asia Pacific, on the other hand, is a lot higher than any other major region, owing to the rapid improvements in healthcare infrastructure and focus on better quality management in countries such as Japan and China.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4741

Biopharmaceutical Companies Top the List of Fragment-based Drug Discovery Demand

Fragment-based drug discovery techniques have grown significantly in popularity in the recent years and have found a great scope of use in the biopharmaceuticals. This includes large companies, academic bodies, and CROs. These techniques have helped massively in creating chemical series that possess lead-like properties as they have improved the success rate of creation significantly over the conventional screening methods. Fragment-based drug discovery techniques have also been extremely useful in marking out chemical motifs from multiple targets.

It is a combination of all these factors that are expected to drive the use of fragment-based drug discovery in biopharmaceutical facilities to a revenue generation of US$565.2 mn by the end of 2023. The key providers of fragment-based drug discovery programs include Astex Pharmaceuticals, Charles River Laboratories International, Inc., Sygnature Discovery, Evotec A.G., and Beactica AB.

# # #


Submitted by hawer on Friday, 19 April 2019 at 8:55 PM
Category: Health Care & Medical
 
Related News

Oral Anti-diabetes Drugs Market Future Opportunities 2025
Thursday, 18 Jul 2019

Blood Plasma Derivatives Market Research and Analyzed Report for 2017 - 2025
Thursday, 18 Jul 2019

Cannabis Testing Market Developments, Growth and 2017 - 2025 Forecast Research Study
Thursday, 18 Jul 2019

Vasculitis Market Research and Analyzed Report for 2016 - 2024
Thursday, 18 Jul 2019

Gouty Arthritis Market Research Key Players, Industry Overview and Forecasts to 2024
Thursday, 18 Jul 2019

Related Events

7th Annual PREDiCT: Tumor Models Boston
Tuesday, 16 Jul 2019

WSAVA Congress & the Canadian Veterinary Medical Association Convention
Tuesday, 16 Jul 2019

4th annual IMPACCT: mHealth in Clinical Trials
Tuesday, 16 Jul 2019

Neurology in Clinical Practice 2019
Thursday, 18 Jul 2019

Current Applications and Future of Artificial Intelligence in Cardiology
Friday, 19 Jul 2019

Latest News

Global TFT LCD Panel Market Estimated to Exceed US$ 208.6 Billion Globally By 2024: IMARC Group
Thursday, 18 Jul 2019

North America CLT Market to Reach a Value of Nearly US$ 171 Million by 2024
Thursday, 18 Jul 2019

Oral Anti-diabetes Drugs Market Future Opportunities 2025
Thursday, 18 Jul 2019

Blood Plasma Derivatives Market Research and Analyzed Report for 2017 - 2025
Thursday, 18 Jul 2019

Immunotherapy Drugs Market Growth and Sales Forecast 2016 - 2024
Thursday, 18 Jul 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Thursday, 18 July 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • 7th Annual PREDiCT: Tumor Models Boston
  • WSAVA Congress & the Canadian Veterinary Medical Association Convention
  • 4th annual IMPACCT: mHealth in Clinical Trials
  • Unbound London 2019
  • Neurology in Clinical Practice 2019

  • Latest Jobs
    Sorry, there are currently no entries posted here.